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treatment of LM disease, PCI with DES and CABG have comparable
mortality (all cause and cardiovascular) during long-term follow-up.
PCI with DES appears to be associated with increased risks of MI and
repeat revascularization.
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BACKGROUND According to the most recent guidelines, percuta-
neous coronary intervention (PCI) with drug eluting stents (DES)
should be considered safe and effective alternative to coronary artery
bypass grafting (CABG) for the treatment of left main (LM) disease in
patients with favorable anatomy (SYNTAX score 32). Conversely in
those with more complex coronary disease (SYNTAX>33) CABG is
favored mainly due to lower rates of revascularization and myocardial
infarction. However, whether the latter it is translated into long-term
mortality beneﬁt it is not clear and merits further investigation.
METHODS A systematic review of the MEDLINE, EMBASE, EBSCO,
CINAHL, Web of Science and COCHRANE databases was conducted in
May 2015. Studies reporting long-term outcomes (at least 4 years
mean follow up) of PCI with DES to CABG for LM disease stratiﬁed by
SS were identiﬁed. Patients were categorized to low/intermediate
(SS32) and high score (SS>33) groups. Random-effects meta-analyses
were performed using risk ratios as the metric of choice.
RESULTS Four studies comprising two randomized control trials
(SYNTAX and PRECOMBAT) and two observational studies (Main-
compare and CREDO-Kyoto), with a total of 3372 patients were
included. 1248 patients (37%) had complex coronary artery disease
(SS>33). Over a mean follow up of 4.9 years, no signiﬁcant difference
in all-cause mortality was observed between PCI and CABG irre-
spective of SYNTAX score strata (Figure 1). Similar ﬁndings were
observed for cardiovascular mortality (SS  32 RR 0.85; 95% 0.41-1.77;
I2 66% for PCI vs. CABG; SS >33 RR 1.25; 95% CI 0.92-1.69; I2 29% for
PCI vs. CABG).
CONCLUSIONS Patients with LM disease appear to have similar risks
of mortality after PCI with DES or CABG regardless of coronary artery
disease burden or complexity during long term follow up.CATEGORIES CORONARY: PCI Outcomes
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BACKGROUND Intense investigation continued on the quality control
of primary percutaneous coronary intervention (PPCI) because of its
high morbidity and mortality. However, little study focused on the
death cause analysis in a large sample. This study is to describe the
current status of acute myocardial infarction treatment in the real
world, facilitate individualized preventive approach for in-hospital
death, and develop a successful quality control/improvement solution
for primary percutaneous coronary intervention in China.
METHODS Data of patients were obtained from Beijing Percutaneous
Coronary InterventionRegistry study (BJPCI Registry,NCT01417325). Each
in-hospital dead case was reviewed and analyzed in the Beijing Cardio-
vascular Intervention Quality Control and Improvement Center quarterly.
RESULTS The study included 19905 acute myocardial infarction patients
(attack tovisiting time< 72h) of 52 centers inBeijing area fromJan.1, 2010 to
Dec 31, 2013. Total in-hospitalmortalitywas 2.30% (total 458 dead cases, 56
cases excluded). Of the included 402 cases, average age was 70.411.2,
91.8%were ST elevatedmyocardial infarction and 55.7%were male. 81.3%
of death occurred during the ﬁrst week after the emergency procedure.
58.5% had anterior wall involved, and 41.5% located in inferior, posterior
wall or rightventricle.Averageattack tovisiting timewas7hour52minutes.
Of all causes of death, the disease severity itself (178, 69.2%) were the pri-
mary factors, including cardiogenic shock (146, 36.3%), mechanical com-
plications (113, 28.1%), and others (19, 4.7%); Followed by the procedure
factors (81, 20.1%), including early stent thrombosis (36, 9.0%), no reﬂow
(30,7.5%), acute thrombosis or embolism(6, 1.5%), perforation or dissection
(4, 1.0%), retroperitoneal hematoma(3, 0.7%) and acute side branch
closure(2, 0.5%); The thirdwas thecomorbidity factors (29, 7.2%), including
septic shock(11, 2.7%), cerebral infarction(10, 2.5%), pulmonary embo-
lism(5,1.2%) and multiple organ failure(3, 0.7%); The last was medicine
factors (14, 3.5%), including intracranial hemorrhage(8, 2.0%), massive
gastrointestinal hemorrhage(5, 1.2%) and anaphylactic shock (1, 0.2%).
47.3% (190) of the dead cases had some sort of medical defects, including
indication (4, 1.0%), rescue measures (60, 14.9%), strategy selection(107,
26.6%)orprocedure issue (19,4.7%).There isnosigniﬁcantdifferenceof the
mortality from 2010 to 2013 (2.23%, 2.55%, 1.94% and 2.48% respectively).
CONCLUSIONS Mortality of acute myocardial infarction remains high,
which have a variety of causes, by order of disease itself, procedure,
comorbidity and medicine factors. The three leading causes of death
were cardiogenic shock, mechanical complications and early stent
thrombosis. Analysis of death causes may contribute to facilitate
